CNBC

The Exchange

"The Exchange" on CNBC is a one-stop shop for the day's top business stories, along with breaking news and the must-see market movers heading into the back half of the trading day. This newsroom-based program also features lots of original reporting, in-depth conversations and showcases CNBC's award-winning investigative work.

Husk at besøge podcastens hjemmeside og støtte skaberen: www.cnbc.com

Forfatter

CNBC

Kategori

Business

Podcastens hjemmeside

www.cnbc.com

Seneste episode

5. nov. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Hent den på Google Play Installer gratis Android næsten 10 mio. downloads · 4,7+ i bedømmelse iOS snart

Episoder

A real rotation?, “One More Thing” and not so divided? 10.11.2020

Investors are fleeing many of the names that have thrived during the pandemic, and piling into recovery plays instead. Should you fade the move or chase it? We’ll debate. Plus, Apple’s last product event before the big holiday shopping season is underway. We’ll bring you the highlights and the trade in real time. And, Wall Street Journal’s Jerry Seib says the election could end up empowering both...

Stocks soar on vaccine developments, and America has a new President-Elect 09.11.2020

Positive vaccine news from Pfizer is sending stocks surging, just as the presidential election was called in Joe Biden’s favor. The Dow, S&P and Russell 2000 all hitting record highs, as there now appears to be a light at the end of the tunnel for the pandemic. We’ll bring you all of the latest details, and will try to answer key questions that remain about the vaccine, its availability and its ef...

Down to the wire, Muni Money and bulls still charging? 06.11.2020

America is still anxiously awaiting the outcome of the presidential race. Key states like Pennsylvania, Arizona and Georgia are all still in play. We’ll bring you the latest vote counts as they happen. Plus, investors appear to be banking on a divided government in the new year. But would gridlock actually be good for the muni market? We’ll debate. And, legendary investor Bill Miller explains why...

Still waiting for a winner 05.11.2020

Stocks are surging again today despite no outcome of the presidential election. We’ll bring you the latest calls from swing states like Georgia, Arizona and Pennsylvania, which are all still in play. Plus, markets are on pace for their biggest weekly gain since April, even while the nation sees a record rise in daily Coronavirus cases. We’ll do a deep dive on the rally, and tell you what to expect...

The Road to 270 04.11.2020

Markets are soaring as votes continue to roll in for the yet-to-be-decided presidential election. We’ll dig into what we know so far, and give you the latest calls from crucial swing states. Plus, our market experts break down what this monster rally should signal to investors.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal d...

Your money, your vote 03.11.2020

It’s a historic day for the country, as millions of Americans vote in an election unlike any other. Stocks are rallying for the second straight session, despite businesses facing a very uncertain future amid the global Coronavirus pandemic. We’ll follow the money, and tell you all you need to know about the polls, the economy and more ahead of tonight’s outcome.  Hosted by Simplecast, an AdsWizz c...

Less than 24 hours to go… 02.11.2020

It’s the eve of the election, and a lot is at stake for investors. From tech regulation, to taxes and energy policy, there’s a ton riding on the outcome. We’ll follow everything you need to know – including the record money pouring into campaigns, and all the possible outcomes for stocks in the coming days. Plus, our own Meg Tirrell explains why Regeneron’s promising COVID-19 antibody treatment wo...

A Wild Week, Redecorating Returns, and Social Media Mistrust 30.10.2020

The Markets continue to lose momentum as we wrap up a red October and with the Presidential Election just four days away. So will the volatility continue into November? We’ll explore. Plus, there’s one stock that has rallied more than 1000% from its lows this year as it benefits from Americans working from home. We’ll tell you the name and talk to the CEO. And, our new all-America Survey shows alm...

Earnings vs. Covid, Tech Titans Report, and Urban Flight Pain 29.10.2020

Since the start of the earnings season, the Dow has dropped 7%, the S&P 5%, and the Nasdaq 4%. Are earnings to blame or is the timing just a coincidence amid the resurgence in Covid cases worldwide? We’ll explore. Plus, with tech earnings on deck, investors have high expectations. We’ll tell you the key things they want to hear from each of the tech titans. And, the recent urban flight is starting...

The selloff continues, and Big Tech on Capitol Hill 28.10.2020

It’s another big down day for stocks, as surging virus cases and new lockdown measures in Europe stoke fears of a halt to the economic recovery. We’ll discuss what’s weighing most on investors’ minds around the globe, and whether or not this is a tipping point or a buying opportunity. Plus, big tech CEOs are back on Capitol Hill, testifying about their controversial content moderation policies. We...

Big beats/small moves, reading the charts, and a worried consumer? 27.10.2020

There’s been a lackluster reaction to the strong earnings reported this season. We’ll discuss what that tells us about the market, and whether or not we’re in a holding pattern until the election. Plus, there’s been a lot of talk about the shift to value names recently…but is the rotation for real? We’ll get technical with Instinet Chief Market Technician Frank Cappelleri. And, the consumer’s outl...

Stocks sell off on virus surge, stimulus stalemate 26.10.2020

The Dow is on pace for its worst day since June, as investors grapple with rising global Coronavirus cases and a stimulus stalemate in Washington. We look at how investors can protect their money, and identify the sectors getting hit hardest by the selloff. Plus, former NEC Director Larry Lindsey joins to discuss volatility ahead of next week’s election, and what rising virus cases could spell for...

Economic fact check, hot homebuilders, and a Barbie boost 23.10.2020

There were a lot of bold claims made about the state of our economy in last night’s presidential debate. We’ll get a fact check, and see who’s doing the best – and worst – right now. Plus, homebuilder stocks are red hot, fueled by high demand and a sizzling housing market. One analyst thinks they can keep up this scorching success up, and he joins to explain. And, Mattel shares are soaring after c...

A “mountain-shaped” market, Quibi calls it quits, and a commodities comeback? 22.10.2020

One of Wall Street’s biggest hedge fund managers says a big rally is ahead once the next relief bill passes. But with no timeline in sight, is it too soon to buy in? We’ll explore. Plus, streaming service Quibi is shutting down just six months after launching, despite a hefty cash hoard and lots of buzz. We discuss what went wrong in Rapid Fire. And, Jeff Currie of Goldman Sachs tells us why he se...

Unused billions, a day (or 2) short, and can Tesla deliver? 21.10.2020

As Washington battles over the next round of stimulus, hundreds of billions of dollars have gone unspent from other sources of funds. Can that cash still be tapped? We’ll explore. Plus, Netflix says it could’ve beaten Q3 estimates…if the quarter lasted an extra 48 hours. We discuss Netflix’s historic earnings miss in Rapid Fire. And, investors have a lot riding on Tesla’s earnings tonight, with th...

DOJ sues Google, checking it twice and Hummer goes electric 20.10.2020

The Dept. of Justice is suing Google, claiming it has a monopoly on the search market. What could this lawsuit accomplish, and will it even matter to the company? We discuss. Plus, the number one retail analyst on Wall Street joins to give us the stock names on his shopping list amid this year’s unprecedented holiday season. And, GM is doubling down on its EV plans, making a multi-billion dollar i...

From the old to the young, the great pickup shortage and M&A mania ahead? 19.10.2020

Stocks are gradually being sold by older folks to younger ones, as Baby Boomers retire and cash out of the market. We’ll explain how that rotation is impacting investors of all ages. Plus, pickup trucks are the hottest model on car lots right now…if you can even find one. We discuss the pandemic’s role in auto demand in Rapid Fire.  And, crude prices continue treading water, as the industry consol...

Avoiding value traps, pressure on Big Tech and a tax holiday for private jets 16.10.2020

How can investors separate future winners from value traps in the hunt for stock bargains? Our market experts weigh in. Plus, big tech firms are under pressure, as antitrust investigations mount and a key liability shield is in doubt. Who’s most at risk? We’ll explore. And, private jet companies are taking advantage of a tax holiday tucked away in the CARES Act. We discuss the potential windfall f...

Shaky Ground, Out of Fashion, and Goodbye Value? 15.10.2020

Rising cases, rising jobless claims and rising doubts about more Covid relief have the markets on shaky ground. We’ll have the latest and see if earnings can help the market. Plus, one analyst says a number of retailers could be negatively impacted if a blue wave sweeps over Washington. He joins us with the names. And, growth stocks have been outperforming value so far this year, now one major val...

Alphabet soup, treatment setbacks and Black Friday(s) 14.10.2020

As the market reverses lower, some investors could be misreading the signs when picking a letter to describe the economic recovery. We’ll explain. Plus, Eli Lilly is pausing its Covid antibody drug trial, now the second virus treatment setback this week. Should investors rethink their strategy in the healthcare space? We’ll debate. And, Walmart is throwing out its Black Friday playbook, and breaki...

Apple’s big event, cash on the sidelines and a “JV” ETF 13.10.2020

Apple kicks off its biggest product event in years, announcing four new 5G- supported iPhone 12 models. We’ll bring you the key details as they break, and tell you all you need to know. Plus, Blackrock CEO Larry Fink says he sees signs of “underlying strength” in the market, including investors sitting on the sidelines who could pump even more cash into stocks. Is he right? Our market experts deba...

Three driving forces, retail’s mega-deal race and the future of live shopping 12.10.2020

There are three big forces at play in the market right now: vaccine, election and earnings. Which will be the biggest catalyst for gains? Our market experts debate. Plus, Amazon Prime Day kicks off after months of delays, and other big box players are cashing in with sales of their own. Who will come out on top? We explore. And, brands like Levi’s and Tommy Hilfiger are betting on QVC-style live p...

Trump Calls for More Stimulus, Energy’s Big Week, Launching a Business During the Pandemic 09.10.2020

Stocks climb on reports that Pres. Trump intends to raise the stimulus offer to $1.8T, but two strategists say the markets going higher with or without a deal. They tell us where they’re seeing opportunities. Oil making big moves this week, and energy getting the of approval from Carl Icahn. Should investors jump in? Plus, despite thousands of small businesses closing, many are also launching duri...

What’s the Deal?, Banking Bonanza, and a Muni Mess? 08.10.2020

Will they or won’t they? Speaker Pelosi says there won’t be a skinny deal for airlines without a broader Covid relief bill. This after the President called talks “productive.” We look at the market impact from all the back and forth. Plus, financials finding some footing recently as we head into a big week of earnings for the sector. We’ll debate what names should be in your portfolio ahead of the...

Stocks like Skinny, Eli Lilly’s Big FDA Move, & a Real Threat to Tech Titans? 07.10.2020

Stocks are rallying as the President proposes smaller, targeted relief aid but do investors believe this is real progress? We debate. Plus, Eli Lilly has filed for FDA emergency use authorization of its Covid-19 antibody drug. We’ll speak with the CEO about the treatment, the potential timeline, and what production could look like. And, in its lengthy report, Congress concludes four big tech giant...

Lyt til podcasten The Exchange i Replaio

Radio og podcasts i én app - gratis og uden tilmelding. Installer i dag, og gå ikke glip af lanceringen

Hent den på Google Play

Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.